Loading insider details...
Latest Form 4 (Jun 24, 2026): Sale of 4,398,519 CNTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Centessa Pharmaceuticals plc (CNTA) | Sale | 4,398,519 | n/a |
| Mar 23, 2022 | Centessa Pharmaceuticals plc (CNTA) | Other (see footnotes) | 1,794,211 | n/a |
| Dec 6, 2021 | Centessa Pharmaceuticals plc (CNTA) | Purchase | 33,530 | $429.9K |
| Dec 2, 2021 | Centessa Pharmaceuticals plc (CNTA) | Purchase | 35,992 | $418.2K |
| Nov 30, 2021 | Centessa Pharmaceuticals plc (CNTA) | Purchase | 11,543 | $130.8K |
| Nov 4, 2021 | Aura Biosciences, Inc. (AURA) | Conversion | 2,275,827 | n/a |
| Jun 4, 2021 | Centessa Pharmaceuticals plc (CNTA) | Conversion | 1,886,990 | n/a |